The Role of Emerging Genomics and Proteomics Technologies in Cancer Drug Target Discovery

Current Cancer Drug Targets

Volumn 4, Issue 2, 2004, Pages 111-124

  Onyango, Patrick ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer drug targets; Genomics; Proteomics; RNA technologies

Indexed keywords

BIOINFORMATICS; CANCER RESEARCH; CELL DEATH; CHROMOSOMAL LOCALIZATION; DRUG MECHANISM; DRUG TARGETING; GENOMICS; HIGH RISK POPULATION; HIGH THROUGHPUT SCREENING; MEDICAL GENETICS; PROTEOMICS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR SUPPRESSOR GENE;

ANIMALS; ANTINEOPLASTIC AGENTS; COMPUTATIONAL BIOLOGY; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; ENDPOINT DETERMINATION; GENOMICS; GENOTYPE; HUMANS; NEOPLASMS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEOMICS; RNA, NEOPLASM;

EID: 1542619347     PISSN: 15680096     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568009043481588     Document Type: Review

References (98)

1. Lander, E. S.; Linton, L. M.; Birren, B.; Nusbaum, C.; Zody, M. C.; Baldwin, J.; Devon, K.; Dewar, K.; Doyle, M.; Fitzhugh, W, et al. Initial Sequencing and Analysis of the Human Genome. Nature 2001, 409, 860-921.
2. Venter, J. C.; Adams, M. D.; Myers, E. W.; Li, P. W.; Mural, R. J.; Sutton, G. G.; Smith, H. O.; Yandell, M.; Evans, C. A.; Holt, R. A.; et al. The Sequence of the Human Genome. Science 2001, 291, 1304-1351.
3. Riggins, G. J.; Strausberg, R. L. Genome and Genetic Resources from the Cancer Genome Anatomy Project. Hum. Mol. Genet. 2001, 10, 663-667.
4. Hieter, P.; Boguski, M. Functional Genomics: It's All How You Read It. Science 1997, 278, 601-602.
5. Evans, W. E.; Relling, M. V. Pharmacogenomics: Translating Functional Genomics Into Rational Therapeutics. Science 1999, 286, 487-91.
6. Vogel, F. Moderne Probleme Der Humangenetik. Ergebnisse Inneren Medizin Und Keinderheilkunde 1959, 12, 52-125.
7. Boveri, T. Uber Mehrpolige Mitosen Als Mittel Zur Analyse Des Zellkerns. Verh. D. Phys. Med. Ges. Wurzberg N. F. 1902, 35, 67-90.
8. Balmain A. Cancer genetics: from Boveri and Mendel to microarrays. Nat. Rev. Cancer 2001, 1, 77-82.
9. Nowell, P.; Hungerford, D. Chromosomes of Normal and Leukemic Human Leucocytes. J. Natl. Cancer Inst. 1960, 25, 85.
10. Park, M. In The Genetic Basis of Human Cancer: Oncogenes; Vogelstein, B; Kinzler, W. K., Eds.: Mcgraw Hill: New York, 1998, Pp. 205-228.
11. Fearon, R. E.: In The Genetic Basis of Human Cancer: Tumor Suppressor Genes; Vogelstein, B; Kinzler, W. K., Eds.; Mcgraw Hill: New York, 1998, Pp. 229-236.
12. Vogelstein, B.; Fearon, E. R.; Hamilton, S. R.; Kern, S. E.; Preisinger, A. C.; Lepper, M.; Nakamura, Y.; White, R.; Smits, A. M.; Bos, J. L. Genetic Alterations During Colorectal-Tumor Development. N. Engl. J. Med. 1988, 319, 525-532.
13. Kinzler, K. W.; Vogelstein, B. Lessons from Hereditary Colorectal Cancer. Cell 1996, 87, 159-70.
14. Strausberg, R. L.; Buetow, K. H.; Emmert-Buck, M. R.; Klausner, R. D. the Cancer Genome Anatomy Project: Building an Annotated Gene Index. Trends Genet. 2000, 16, 103-106.
15. Loging, W. T.; Lal, A.; Siu, I. M.; Loney, T. L.; Wikstrand, C. J.; Marra, M. A.; Prange, C.; Bigner, D. D.; Strausberg, R. L.; Riggins, G. J. Identifying Potential Tumor Markers and Antigens by Database Mining and Rapid Expression Screening. Genome Res. 2000, 10, 1393-402.
16. Strausberg, R. L.; Greenhut, S. F.; Grouse, L. H.; Schaefer, C. F.; Buetow, K. H. In Silico Analysis of Cancer through the Cancer Genome Anatomy Project. Trends Cell Biol. 2001, 11, S66-71.
17. Wu, J.; Grunstein, M. 25 Years after the Nucleosome Model: Chromatin Modifications. Trends Biochem. Sci. 2000, 25, 619-623.
18. Feinberg, A. P.; Vogelstein, B. Hypomethylation Distinguishes Genes of Some Human Cancers from Their Normal Counterparts. Nature 1983, 301, 89-92.
19. Zhang, Y.; Shields, T.; Crenshaw, T.; Hao, Y.; Moulton, T.; Tycko, B. Imprinting of Human H19: Allele-Specific CpG Methylation, Loss of the Active Allele in Wilms Tumor, and Potential for Somatic Allele Switching. Am. J. Hum. Genet. 1993, 53, 113-124.
20. Costello, J. F.; Fruhwald, M. C.; Smiraglia, D. J.; Rush, L. J.; Robertson, G. P.; Gao, X.; Wright, F. A.; Feramisco, J. D.; Peltomaki, P.; Lang, J. C.; Schuller, D. E.; Yu, L.; Bloomfield, C. D.; Caligiuri, M. A.; Yates, A. ; Nishikawa, R.; Su Huang, H.; Petrelli, N. J.; Zhang, X,; O'Dorisio, M. S.; Held, W. A.; Cavenee, W. K.; Plass, C. Aberrant CpG-Island Methylation Has Non-Random and Tumour-Type-Specific Patterns. Nat. Genet. 2000, 24, 132-138.
21. Brown, R.; Strathdee, G. Epigenomics and Epigenetic Therapy of Cancer. Trends Mol. Med. 2002, 8, S43-48.
22. Brinckerhoff, C. E.; Matrisian, L. M. Matrix Metalloproteinases: a Tail of a Frog That Became a Prince. Nat. Rev. Mol. Cell Biol. 2002, 3, 207-214.
23. Egeblad, M.; Werb, Z. New Functions for the Matrix Metalloproteinases in Cancer Progression. Nat. Rev. Cancer 2002, 2, 161-174.
24. Mccullagh, K.; Wadsworth, H.; Hann, M. Carboxyalkyl Peptide Derivatives. European Patent Application 1984, EU 126, 974, Pp 1-111.
25. Lopez-Otin, C.; Overall, C. M. Protease Degradomics: a New Challenge for Proteomics. Nat. Rev. Mol. Cell Biol. 2002, 3, 509-519.
26. Schena, M.; Shalon, D.; Davis, R. W.; Brown, P. O. Quantitative Monitoring of Gene-Expression Patterns with a Complementary-DNA Microarray. Science 1995, 270, 467-470.
27. Lipshutz R. J.; Fodor, S. P. A.; Gingeras, T. R.; Lockhart, D. J. High Density Synthetic Oligonucleotide Arrays. Nat. Genetics 1999, 21, 20-24.
28. Velculescu, V. E.; Zhang, L.; Vogelstein, B.; Kinzler, K. W. Serial Analysis of Gene-Expression. Science 1995, 270, 484-487.
29. Mills, A. A.; Bradley, A. From Mouse to Man: Generating Megabase Chromosome Rearrangements. Trends Genet. 2001, 17, 331-339.
30. Levskry, J. M.; Shenoy, S. M.; Pezo, R. C.; Singer, R. H. Single-Cell Gene Expression Profiling. Science 2002, 297, 836-840.
31. Cai, W. W.; Mao, J. H.; Chow, C. W.; Damani, S.; Balmain, A.; Bradley, A. Genome-Wide Detection of Chromosomal Imbalances in Tumors Using BAC Microarrays. Nat. Biotechnol. 2002, 20, 393-396.
32. Lee, J. S.; Thorgeirsson, S. S. Functional and Genomic Implications of Global Gene Expression Profiles in Cell Lines from Human Hepatocellular Cancer. Hepatology 2002, 35, 1134-1143.
33. Schoch, C.; Kohlmann, A.; Schnittger, S.; Brors, B.; Dugas, M.; Mergenthaler, S.; Kern, W.; Hiddemann, W.; Eils, R.; Haferlach, T. Acute Myeloid Leukemias with Reciprocal Rearrangements Can Be Distinguished by Specific Gene Expression Profiles. Proc. Natl. Acad. Sci. USA 2002, 99, 10008-10013.
34. Miller, J. D.; Stacy, T.; Liu, P. P.; Speck, N. A. Core-Binding Factor Beta (Cbfbeta), But Not Cbfbeta-Smooth Muscle Myosin Heavy Chain, Rescues Definitive Hematopoiesis In Cbfbeta-Deficient Embryonic Stem Cells. Blood 2001, 97, 2248-2256.
35. Gelmetti, V.; Zhang, J.; Fanelli, M.; Minucci, S.; Pelicci, P. G.; Lazar, M. A. Aberrant Recruitment of the Nuclear Receptor Corepressor-Histone Deacetylase Complex by the Acute Myeloid Leukemia Fusion Partner ETO. Mol. Cell. Biol. 1998, 18, 7185-7191.
36. Beer, D. G.; Kardia, S. L.; Huang, C. C.; Giordano, T. J.; Levin, A. M.; Misek, D. E.; Lin, L.; Chen, G.; Gharib, T. G.; Thomas, D. G.; Lizyness, M. L.; Kuick, R.; Hayasaka, S.; Taylor, J. M.; Iannettoni, M. D.; Orringer, M. B.; Hanash S. Gene-Expression Profiles Predict Survival of Patients With Lung Adenocarcinoma. Nat. Medicine 2002, 8, 816-824.
37. Peifer, M. β-Catenin as Oncogene: the Smoking Gun. Science 1997, 275, 1752-1753.
38. Morin, P. β-Catenin Signaling and Cancer. Bioessays 1999, 21, 1021-1030.
39. Zhurinsky, J.; Shtutman, M.; and Ben-Ze'ev, A. Plakoglobin and β-Catenin: Protein Interactions, Regulation and Biological Roles. J Cell Sci. 2000, 113, 3127-3139.
40. Polakis, P. Wnt Signaling and Cancer. Genes Dev. 2000, 14, 1837-1851.
41. Grumet, M.; Mauro, V.; Burgoon, M. P.; Edelman, G. M.; Cunningham, B. A. Structure of a New Nervous System Glycoprotein, Nr-CAM, and Its Relationship to Subgroups of Neural Cell Adhesion Molecules. J. Cell Biol. 1991, 113, 1399-1412.
42. Conacci-Sorrell, M. E.; Ben-Yedidia, T.; Shtutman, M.; Feinstein, E.; Einat, P.; Ben-Ze'ev, A. Nr-CAM Is a Target Gene of the Beta-Catenin/LEF-1 Pathway In Melanoma and Colon Cancer and Its Expression Enhances Motility and Confers Tumorigenesis. Genes Dev. 2002, 16, 2058-2072.
43. Takahashi, M.; Tsunoda, T.; Seiki, M.; Nakamura, Y.; Furukawa, Y. Identification of Membrane-Type Matrix Metalloproteinase-1 as a Target of the Beta-Catenin/Tcf4 Complex In Human Colorectal Cancers. Oncogene 2002, 21, 5861-5867.
44. Frolov A.; Prowse, A. H.; Vanderveer, L.; Bove, B.; Wu, H.; Godwin, A. K. DNA Array-Based Method for Detection of Large Rearrangements in the BRCA1 Gene. Genes Chromosomes Cancer 2002, 35, 232-241.
45. Pollack, J. R.; Sorlie, T.; Perou, C. M.; Rees, C. A.; Jeffrey, S. S.; Lonning, P. E.; Tibshirani, R.; Botstein, D.; Borresen-Dale, A. L.; Brown, P. O. Microarray Analysis Reveals a Major Direct Role of DNA Copy Number Alteration In the Transcriptional Program of Human Breast Tumors. Proc. Natl. Acad. Sci. USA 2002, 99, 12963-12968.
46. Aul, C.; Gattermann, N.; Schneider, W.: Age-Related Incidence and Other Epidemiological Aspects of Myelodysplastic Syndromes. Br. J. Haematol. 1992, 82, 358-367.
47. Miyazato, A.; Ueno, S.; Ohmine, K.; Ueda, M.; Yoshida, K.; Yamashita, Y. ; Kaneko, T.; Mori, M.; Kirito, K.; Toshima, M.; Nakamura, Y.; Saito, K.; Kano, Y.; Furusawa, S.; Ozawa, K.; Mano, H.: Identification of Myelodysplastic Syndrome-Specific Genes by DNA Microarray Analysis with Purified Hematopoietic Stem Cell Fraction. Blood 2001, 98, 422-427.
48. Zardo, G.; Tiirikainen, M. I.; Hong, C.; Misra, A.; Feuerstein, B. G.; Volik, S.; Collins, C. C.; Lamborn, K. R.; Bollen, A.; Pinkel, D.; Albertson, D. G.; Costello, J. F. Integrated Genomic and Epigenomic Analyses Pinpoint Biallelic Gene Inactivation in Tumors. Nat. Genet. 2002, 32, 53-58.
49. Morita, Y.; Naka, T.; Kawazoe, Y.; Fujimoto, M.; Narazaki, M.; Nakagawa, R.; Fukuyama, H.; Nagata, S.; Kishimoto, T. Signals Transducers and Activators of Transcription (STAT)-Induced STAT Inhibitor-1 (SSI-1)/Suppressor of Cytokine Signaling-1 (SOCS-1) Suppresses Tumor Necrosis Factor Alpha-Induced Cell Death in Fibroblasts. Proc. Natl. Acad. Sci. USA 2000, 97, 5405-5410.
50. Kawazoe, Y.; Naka, T.; Fujimoto, M.; Kohzaki, H.; Morita, Y.; Narazaki, M.; Okumura, K.; Saitoh, H.; Nakagawa, R.; Uchiyama, Y.; Akira, S.; Kishimoto, T. Signal Transducer and Activator of Transcription (STAT)-Induced STAT Inhibitor 1 (SSI-1)/Suppressor of Cytokine Signaling 1 (SOCS1) Inhibits Insulin Signal Transduction Pathway Through Modulating Insulin Receptor Substrate 1 (IRS-1) Phosphorylation. J. Exp. Med. 2001, 193, 263-269.
51. De Sepulveda, P.; Ilangumaran, S.; Rottapel, R. Suppressor of Cytokine Signaling-1 Inhibits VAV Function through Protein Degradation. J. Biol. Chem. 2000, 275, 14005-14008.
52. Fire, A.; Xu, S. Q.; Montgomery, M. K.; Kostas, S. A.; Driver, S. E.; Mello, C. C. Potent and Specific Genetic Interference by Double-Stranded RNA in Caenorhabditis Elegans. Nature 1998, 391, 806-811.
53. Gonczy, P.; Echeverri, C.; Oegema, K.; Coulson, A.; Jones, S.J.; Copley, R. R.; Duperon, J.; Oegema, J.; Brehm, M.; Cassin, E.; Hannak, E.; Kirkham, M.; Pichler, S.; Flohrs, K.; Goessen, A.; Leidel, S.; Alleaume, A. M.; Martin, C.; Ozlu, N.; Bork, P.; Hyman, A. A. Functional Genomic Analysis of Cell Division in C. Elegans Using RNAi of Genes on Chromosome III. Nature 2000, 408, 331-336.
54. Brummelkamp, T. R.; Bernards, R.; Agami, R. Stable Suppression of Tumorigenicity by Virus-Mediated RNA Interference. Cancer Cell 2002, 2, 243-247.
55. Kennerdell, J. R.; Carthew, R. W. Heritable Gene Silencing in Drosophila Using Double-Stranded RNA. Nat. Biotechnol. 2000, 18, 896-898.
56. Kruger, K.; Grabowski, P. J.; Zaug, A. J.; Sands, J.; Gottschling, D. E. ; Cech, T. R. Self-Splicing RNA: Autoexcision and Autocyclization of the Ribosomal RNA Intervening Sequence of Tetrahymena. Cell 1982, 31, 147-157.
57. Guerrier-Takada, C.; Gardiner, K.; Marsh, T.; Pace, N.; Altman, S. The RNA Moiety of Ribonuclease P Is the Catalytic Subunit of the Enzyme. Cell 1983, 35, 2849-2857.
58. Symons, R. H. Small Catalytic Rnas. Annu. Rev. Biochem. 1992, 61, 641-671.
59. Usman, N.; Blatt, L. M. Nuclease-Resistant Synthetic Ribozymes: Developing a New Class of Therapeutics. J. Clin. Invest. 2000, 106, 1197-1202.
60. Pavco, P. A.; Bouhana, K. S.; Gallegos, A. M.; Agrawal, A.; Blanchard, K. S.; Grimm, S. L.; Jensen, K. L.; Andrews, L. E.; Wincott, F. E.; Pitot, P. A.; Tressler, R. J.; Cushman, C.; Reynolds, M. A.; Parry, T. J. Antitumor and Antimetastatic Activity of Ribozymes Targeting the Messenger RNA of Vascular Endothelial Growth Factor Receptors. Clin. Cancer. Res. 2000, 6, 2094-2103.
61. Kashani-Sabet, M.; Liu, Y.; Fong, S.; Desprez, P. Y.; Liu, S.; Tu, G.; Nosrati, M.; Handumrongkul, C.; Liggitt, D.; Thor, A. D.; Debs, R. J. Identification of gene function and functional pathways by systemic plasmid-based ribozyme targeting in adult mice. Proc. Natl. Acad. Sci. U S A. 2002, 99, 3878-3883.
62. Sauer, B.; Henderson, N. Site-Specific DNA Recombination In Mammalian Cells by the Cre Recombinase of Bacteriophage P1. Proc. Natl. Acad. Sci. USA 1988, 85, 5166-5170.
63. Ramirez-Solis, R.; Liu, P.; Bradley, A. Chromosome Engineering in Mice. Nature 1995, 378, 720-724.
64. Sauer, B. Inducible Gene Targeting in Mice Using the Cre/Lox System. Methods 1998, 14, 381-392.
65. Jonkers, J.; Berns, A. Conditional Mouse Models of Sporadic Cancer. Nat. Rev. Cancer 2002, 2, 251-265.
66. Sager, R.; Tanaka, K.; Lau, C. C.; Ebina, Y.; Anisowicz, A. Resistance of Human Cells To Tumorigenesis Induced by Cloned Transforming Genes. Proc. Natl. Acad. Sci. USA 1983, 80, 7601-7605.
67. Hahn, W. C.; Weinberg, R. A. Modelling the Molecular Circuitry of Cancer. Nat. Rev. Cancer 2002, 2, 331-341.
68. Jacks, T.; Fazeli, A.; Schmitt, E. M.; Bronson, R. T.; Goodell, M. A.; Weinberg, R. A. Effects of an Rb Mutation in the Mouse. Nature 1992, 359, 295-300.
69. Giaever, G.; Chu, A. M.; Ni, L. et al. Functional Profiling of the Saccharomyces Cerevisiae Genome. Nature 2002, 418, 387-391.
70. Bjornsti, M. A. Cancer Therapeutics In Yeast. Cancer Cell 2002, 2, 267-273.
71. Rubin, G. M.; Yandell, M. D.; Wortman, J. R. et al. Comparative Genomics of the Eukaryotes. Science 2000, 287, 2204-2215.
72. Aparicio, S.; Chapman, J.; Stupka, E. et al. Whole-Genome Shotgun Assembly and Analysis of the Genome of Fugu Rubripes. Science 2002, 297, 1301-1310.
73. Su, A. I.; Cooke, M. P.; Ching, K. A.; Hakak, Y.; Walker, J. R.; Wiltshire, T.; Orth, A. P.; Vega, R. G.; Sapinoso, L. M.; Moqrich, A.; Patapoutian, A.; Hampton, G. M.; Schultz, P. G.; Hogenesch, J. B. Large-Scale Analysis of the Human and Mouse Transcriptomes. Proc. Natl. Acad. Sci. USA 2002, 99, 4465-4470.
74. Henttu, P.; Vihko, P. Prostate-Specific Antigen and Human Glandular Kallikrein: Two Kallikreins of the Human Prostate. Ann. Med. 1994, 26, 1571-64.
75. Wang, D. G.; Fan, J. B.; Siao, C. J. et al. Large-Scale Identification, Mapping, and Genotyping of Single-Nucleotide Polymorphisms in the Human Genome. Science 1998, 280, 1077-1082.
76. Kirk, B. W.; Feinsod, M.; Favis, R.; Kliman, R. M.; Barany, F. Single Nucleotide Polymorphism Seeking Long Term Association with Complex Disease. Nucleic Acids Res. 2002, 30, 3295-3311.
77. Zhou, W.; Goodman, S. N.; Galizia, G.; Lieto, E.; Ferraraccio, F.; Pignatelli, C.; Purdie, C. A.; Piris, J.; Morris, R.; Harrison, D. J.; Paty, P. B.; Culliford, A.; Romans, K. E.; Montgomery, E. A.; Choti, M. A.; Kinzler, K. W.; Vogelstein, B. Counting Alleles to Predict Recurrence of Early-Stage Colorectal Cancers. Lancet 2002, 359, 219-225.
78. Primdahl, H.; Wikman, F. P.; Von Der Maase, H.; Zhou, X. G.; Wolf, H.; Orntoft, T. F. Allelic Imbalances in Human Bladder Cancer: Genome-Wide Detection with High-Density Single-Nucleotide Polymorphism Arrays. J. Natl. Cancer. Inst. 2002, 94, 216-223.
79. Hawkins, G. A.; Mychaleckyj, J. C.; Zheng, S. L.; Faith, D. A.; Kelly, B.; Isaacs, S. D.; Wiley, K. E.; Chang, B. L.; Ewing, C. M.; Bujnovszky, P.; Bleecker, E. R.; Walsh, P. C.; Meyers, D. A.; Isaacs, W. B.; Xu, J. Germline Sequence Variants of the LZTS1 Gene Are Associated with Prostate Cancer Risk. Cancer Genet. Cytogenet. 2002, 137, 1-7.
80. Prokunina, L.; Castillejo-Lopez, C.; Oberg, F.; Gunnarsson, I.; Berg, L. ; Magnusson, V.; Brookes, A. J.; Tentler, D.; Kristjansdottir, H.; Grondal, G.; Bolstad, A. I.; Svenungsson, E.; Lundberg, I.; Sturfelt, G.; Jonssen, A.; Truedsson, L.; Lima, G.; Alcocer-Varela, J.; Jonsson, R.; Gyllensten, U. B.; Harley, J. B.; Alarcon-Segovia, D.; Steinsson, K.; Alarcon-Riquelme, M. E. A Regulatory Polymorphism in PDCD1 Is Associated with Susceptibility to Systemic Lupus Erythematosus In Humans. Nat Genet. 2002, 32, 666-669.
81. Fujiwara, K.; Poikonen, K.; Aleman, L.; Valtavaara, M.; Saksela, K.; Mayer, B. J. A Single-Chain Antibody/Epitope System for Functional Analysis of Protein-Protein Interactions. Biochemistry 2002, 41, 12729-12738.
82. Yarmush, M. L.; Jayaraman, A. Advances in Proteomic Technologies. Annu. Rev. Biomed. Eng. 2002, 4, 349-373.
83. Schmid, M. B. Structural Proteomics: the Potential of High-Throughput Structure Determination. Trends Microbiol. 2002, 10, S27-31.
84. Appel, R. D.; Sanchez, J. C.; Bairoch, A.; Golaz, O.; Miu, M.; Vargas, J. R.; Hochstrasser, D. F. SWISS-2DPAGE: a Database of Two-Dimensional Gel Electrophoresis Images. Electrophoresis 1993, 14, 1232-1238.
85. Hunt, D. F.; Henderson, R. A.; Shabanowitz, J.; Sakaguchi, K.; Michel, H.; Sevilir, N.; Cox, A. L.; Appella, E.; Engelhard, V. H. Characterization of Peptides Bound to the Class 1 MHC Molecule HLA-A2.1 by Mass Spectrometry. Science 1992, 255, 1261-1263.
86. Fields, S.; Song, O. A Novel Genetic System to Detect Protein-Protein Interactions. Nature 1989, 340, 245-246.
87. Chien, C. T.; Bartel, P. L.; Sternglanz, R.; Fields, S. The 2-Hybrid System - a Method to Identify and Clone Genes for Proteins That Interact with a Protein of Interest. Proc. Natl. Acad. Sci. USA 1991, 88, 9578-9582.
88. Russell, R. B. Genomics, Proteomics and Bioinformatics: All in the Same Boat. Genome Biol. 2002, 3, 4034.
89. Sawasaki, T.; Ogasawara, T.; Morishita, R.; Endo, Y. A Cell-Free Protein Synthesis System For High-Throughput Proteomics. Proc. Natl. Acad. Sci. USA 2002, 99, 14652-14657.
90. rd.; Ornstein, D. K.; Paweletz, C. P.; Ardekani, A.; Hackett, P. S.; Hitt, B. A.; Velassco, A.; Trucco, C.; Wiegand, L.; Wood, K.; Simone, C. B.; Levine, P. J.; Linehan, W. M.; Emmert-Buck, M. R.; Steinberg, S.M.; Kohn, E. C.; Liotta, L. A. Serum Proteomic Patterns for Detection of Prostate Cancer. J. Natl. Cancer. Inst. 2002, 94, 1576-1578.
91. Weinschenk, T.; Gouttefangeas, C.; Schirle, M.; Obermayr, F.; Walter, S. ; Schoor, O.; Kurek, R.; Loeser, W.; Bichler, K. H.; Wernet, D.; Stevanovic, S. ; Rammensee, H. G. Integrated Functional Genomics Approach for the Design of Patient-Individual Antitumor Vaccines. Cancer Res. 2002, 62, 5818-5827.
92. Bera, T. K.; Lee, S.; Salvatore, G.; Lee, B.; Pastan, I. MRP8, a New Member of ABC Transporter Superfamily, Identified by EST Database Mining and Gene Prediction Program, Is Highly Expressed in Breast Cancer. Mol. Med. 2001, 7, 509-516
93. Gonzalez, F. J.; Skoda, R. C.; Kimura, S.; Umeno, M.; Zanger, U. M.; Nebert, D. W.; Gelboin, H. V.; Hardwick, J. P.; Meyer, U. A. Characterization of the Common Genetic Defect In Humans Deficient In Debrisoquine Metabolism. Nature 1988, 331, 442-446.
94. Relling M. V.: Dervieux T. Pharmacogenetics and Cancer Therapy. Nat. Rev. Cancer. 2001, 1, 99-108.
95. Kwok, P. Y. High-Throughput Genotyping Assay Approaches. Pharmacogenomics 2000, 1, 95-100
96. O'Dwyer, M. E.; Rathbun, K.; Druker, B. J.; Bagby, G. C. STI 571 Induces Apoptosis of Bcr-Abl Positive Cells In Vitro; the Roles of Caspase 3, 9 and TRAIL. Blood 2000, 96, 343a-343a.
97. Evans, W. E.; Relling, M. V. Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics. Science 1999, 286, 487-491.
98. Shah, N. P.; Nicoll, J. M.; Nagar, B.; Gorre, M. E.; Paquette, R. L, Kuriyan J, Sawyers, C. L. Multiple BCR-ABL Kinase Domain Mutations Confer Polyclonal Resistance to the Tyrosine Kinase Inhibitor Imatinib (ST1571) in Chronic Phase and Blast Crisis Chronic Myeloid Leukemia. Cancer Cell 2002, 2, 117-125.